Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry.

Marisa IborraBelén BeltránAgnes Fernández-ClotetEva Iglesias-FloresPablo NavarroMontserrat RiveroAna GutiérrezMónica Sierra-AusinFrancisco MesoneroRocío Ferreiro-IglesiasJoaquín HinojosaXavier CalvetBeatriz SiciliaCarlos González-MuñozaBeatriz AntolínMaría González-VivoAna Y CarbajoSantiago García-LópezAlbert Martín-CardonaGerard SurísMaría Dolores Martin-ArranzRuth de FranciscoFiorella CañeteEugeni DomènechPilar Nosnull null

Published in: Alimentary pharmacology & therapeutics (2020)

After 52 weeks, ustekinumab demonstrated effectiveness in inducing clinical and endoscopic remission in patients with refractory CD.

Keyphrases

randomized controlled trial
systematic review
disease activity
gestational age
preterm birth